Evommune, Inc. EVMN
Set alert
6.73 USD -0.08 -1.17%
At close · Oct 30
6.25 -0.48 -7.08%
After hours · Oct 30, 6:02 PM ET
6.29 Day range 6.84
5.10 52-week range 31.57
- YTD
- -60.69%
- 1 year
- -66.73%
- Open
- 6.65
- Prev close
- 6.81
- Mkt cap
- 244.25M
- Vol
- 586.35K
- Avg vol
- 787.66K
- EPS
- -3.75
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.29
- High
- 6.84
1m chart
Built from the cached one-day intraday bars.
Signals (64)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 3:55 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:53 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:46 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:46 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 3:46 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:45 PM | 2 days ago |
| RSI: Overbought | Oct 30, 3:36 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:14 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:11 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:08 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:02 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:59 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:42 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:31 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:25 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:25 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:23 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:23 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:19 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:14 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:14 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:14 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:02 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:01 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:01 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 1:57 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 1:46 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 1:43 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:39 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:32 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 1:32 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 1:19 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:14 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 1:11 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:10 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:59 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:56 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:54 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:43 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:42 PM | 2 days ago |
| RSI: Overbought | Oct 30, 12:41 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:39 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:24 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:06 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 11:39 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:38 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:36 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:31 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:30 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:27 AM | 2 days ago |
| RSI: Overbought | Oct 30, 11:23 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 11:20 AM | 2 days ago |
| RSI: Overbought | Oct 30, 11:00 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:58 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:53 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:36 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:28 AM | 2 days ago |
| RSI: Oversold | Oct 30, 10:17 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:12 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:57 AM | 2 days ago |
Financials — quick view
EVMN Revenue — quarterly 0
EVMN Net income — quarterly -32.25M
EVMN EPS — quarterly -0.89
News
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- UBS Initiates Coverage On Evommune with Neutral Rating, Announces Price Target of $8
- Evommune Presents Additional Data From Phase 2a Proof-Of-Concept Trial Of EVO301 In Adults With Atopic Dermatitis At EADV 2026 Congress; Plan To Initiate Subcutaneous Phase 2b Dose-Ranging Trial In Mid-2027
- Evommune Presents Late-Breaking Phase 2a Proof-of-Concept Data Evaluating EVO301 in Atopic Dermatitis at European Academy of Dermatology and Venereology Congress
- Evommune To Present Results From Phase 2a Study Of EVO301 In Moderate-To-Severe Atopic Dermatitis At European Academy Of Dermatology & Venereology Congress
- Evommune Announces Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology 2026 Congress
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Leerink Partners Maintains Outperform on Evommune, Lowers Price Target to $22
- RBC Capital Maintains Outperform on Evommune, Lowers Price Target to $21
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Your note
Sign in to keep a note on EVMN — it syncs with the Stock Master app.